Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Haematologica
|
August 2, 2016
Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores
Monika Engelhardt, Sandra Maria Dold, Gabriele Ihorst, et al.
Cancers
|
September 10, 2021
Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors
Laura Gengenbach, Giulia Graziani, Heike Reinhardt, et al.
Clinical and Experimental Nephrology
|
August 22, 2018
GFR estimation in lenalidomide treatment of multiple myeloma patients: a prospective cohort study
Andrea Schmidts, Julian Grünewald, Martina Kleber, et al.
Haematologica
|
July 11, 2015
Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years
Monika Engelhardt, Gabriele Ihorst, Ola Landgren, et al.
Leukemia & Lymphoma
|
March 24, 2018
Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials<sup/>
Laura Gengenbach, Heike Reinhardt, Gabriele Ihorst, et al.
Cancer
|
January 30, 2019
Avoiding chemotherapy prescribing errors: Analysis and innovative strategies
Heike Reinhardt, Petra Otte, Alison G Eggleton, et al.
Haematologica
|
November 3, 2022
An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence
Maximilian Holler, Gabriele Ihorst, Heike Reinhardt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 14, 2017
Paving the Way for Dose Banding of Chemotherapy: An Analytical Approach
Heike Reinhardt, Rainer Trittler, Alison G Eggleton, et al.
Haematologica
|
February 4, 2017
A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients
Monika Engelhardt, Anne-Saskia Domm, Sandra Maria Dold, et al.
Annals of Hematology
|
June 5, 2025
Ixazomib-lenalidomid-dexamethasone (IRd) in relapsed refractory multiple myeloma (RRMM)-multicenter real-world analysis from Germany and comparative review of the literature
Hanna Löffler, Magdalena Braun, Heike Reinhardt, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Haematologica
|
August 2, 2016
Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores
Monika Engelhardt, Sandra Maria Dold, Gabriele Ihorst, et al.
Cancers
|
September 10, 2021
Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors
Laura Gengenbach, Giulia Graziani, Heike Reinhardt, et al.
Clinical and Experimental Nephrology
|
August 22, 2018
GFR estimation in lenalidomide treatment of multiple myeloma patients: a prospective cohort study
Andrea Schmidts, Julian Grünewald, Martina Kleber, et al.
Haematologica
|
July 11, 2015
Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years
Monika Engelhardt, Gabriele Ihorst, Ola Landgren, et al.
Leukemia & Lymphoma
|
March 24, 2018
Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials<sup/>
Laura Gengenbach, Heike Reinhardt, Gabriele Ihorst, et al.
Cancer
|
January 30, 2019
Avoiding chemotherapy prescribing errors: Analysis and innovative strategies
Heike Reinhardt, Petra Otte, Alison G Eggleton, et al.
Haematologica
|
November 3, 2022
An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence
Maximilian Holler, Gabriele Ihorst, Heike Reinhardt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 14, 2017
Paving the Way for Dose Banding of Chemotherapy: An Analytical Approach
Heike Reinhardt, Rainer Trittler, Alison G Eggleton, et al.
Haematologica
|
February 4, 2017
A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients
Monika Engelhardt, Anne-Saskia Domm, Sandra Maria Dold, et al.
Annals of Hematology
|
June 5, 2025
Ixazomib-lenalidomid-dexamethasone (IRd) in relapsed refractory multiple myeloma (RRMM)-multicenter real-world analysis from Germany and comparative review of the literature
Hanna Löffler, Magdalena Braun, Heike Reinhardt, et al.
Page
of 2